Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine response in adults with predominantly antibody deficiency
Background: Patients with predominantly antibody deficiency (PAD) have lower anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibody levels after initial 2-dose SARS-CoV-2 vaccination than healthy controls do; however, the anti-spike antibody responses and neutralization fun...
| Published in: | Journal of Allergy and Clinical Immunology: Global |
|---|---|
| Main Authors: | Anna M. Zhang, MD, Ahmed Elmoursi, MD, MPH, Daniel V. DiGiacomo, MD, MPH, Baijun Zhou, MHS, Megha Tandon, BA, Joseph S. Hong, BS, Nancy J. Yang, BS, Mei-Sing Ong, PhD, Anand S. Dighe, MD, PhD, Cristhian Berrios, MD, Mark C. Poznansky, MD, PhD, Anthony J. Iafrate, MD, PhD, Vivek Naranbhai, PhD, MB, ChB, Alejandro Balazs, PhD, Shiv Pillai, MBBS, PhD, Jocelyn R. Farmer, MD, PhD, Sara Barmettler, MD |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-05-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772829324000304 |
Similar Items
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma
by: Yuji Uehara, MD, et al.
Published: (2025-03-01)
by: Yuji Uehara, MD, et al.
Published: (2025-03-01)
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
by: Ragnhild J. Måseide, MD, PhD, et al.
Published: (2024-11-01)
by: Ragnhild J. Måseide, MD, PhD, et al.
Published: (2024-11-01)
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC
by: Jay M. Lee, MD, et al.
Published: (2025-08-01)
by: Jay M. Lee, MD, et al.
Published: (2025-08-01)
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study
by: Ji-Su Shim, MD, PhD, et al.
Published: (2023-12-01)
by: Ji-Su Shim, MD, PhD, et al.
Published: (2023-12-01)
Systemic Oxidative Stress Level as a Pathological and Prognostic Factor in Myopic Choroidal Neovascularization
by: Jiying Wang, MD, PhD, et al.
Published: (2024-11-01)
by: Jiying Wang, MD, PhD, et al.
Published: (2024-11-01)
Histological analysis of psoriasiform eruption associated with myelin oligodendrocyte glycoprotein antibody-associated disease
by: Saori Itoi-Ochi, MD, PhD, et al.
Published: (2024-04-01)
by: Saori Itoi-Ochi, MD, PhD, et al.
Published: (2024-04-01)
Novel pretransplant desensitization strategies in heart transplantation
by: Guillaume Coutance, MD, PhD, et al.
Published: (2025-05-01)
by: Guillaume Coutance, MD, PhD, et al.
Published: (2025-05-01)
Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin
by: Eric H. Kowalski, MD, et al.
Published: (2023-11-01)
by: Eric H. Kowalski, MD, et al.
Published: (2023-11-01)
Livedo racemosa as the presenting symptom of microscopic polyangiitis
by: Christine Li, BS, et al.
Published: (2025-09-01)
by: Christine Li, BS, et al.
Published: (2025-09-01)
Comparison of salivary and serum IgG antibody in diagnosis of Helicobacter Pylori
by: M.Nasrolahei (Ph.D), et al.
Published: (2003-03-01)
by: M.Nasrolahei (Ph.D), et al.
Published: (2003-03-01)
Clinical utility of 1:16 serum dilution as a predictor of response to therapeutic plasma exchange for HLA antibody-mediated rejection treatment and overall survival in lung transplant recipients: A two center study
by: Mohamed Elrefaei, MD PhD, et al.
Published: (2025-08-01)
by: Mohamed Elrefaei, MD PhD, et al.
Published: (2025-08-01)
Targeting MET in NSCLC: An Ever-Expanding Territory
by: Ying Han, MD, et al.
Published: (2024-02-01)
by: Ying Han, MD, et al.
Published: (2024-02-01)
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5
by: Anas Gazzah, MD, et al.
Published: (2025-10-01)
by: Anas Gazzah, MD, et al.
Published: (2025-10-01)
Associations between Progression of Retinal Pigment Epithelial and Outer Retinal Atrophy and Choroidal Thickness: A 2-Year observation
by: Norihiro Nagai, MD, PhD, et al.
Published: (2026-01-01)
by: Norihiro Nagai, MD, PhD, et al.
Published: (2026-01-01)
Relationship between Full-Thickness Macular Hole Onset and Posterior Vitreous Detachment
by: Hirokazu Sakaguchi, MD, PhD, et al.
Published: (2023-12-01)
by: Hirokazu Sakaguchi, MD, PhD, et al.
Published: (2023-12-01)
Independent association of a 17q21 variant with exacerbations in type 2–low adult asthma
by: Yumi Ishiyama, MD, et al.
Published: (2025-08-01)
by: Yumi Ishiyama, MD, et al.
Published: (2025-08-01)
Jug r 1 sensitization in 0- to 35-month-old children with egg, milk, or wheat sensitization
by: Katsumasa Kitamura, MD, PhD, et al.
Published: (2023-11-01)
by: Katsumasa Kitamura, MD, PhD, et al.
Published: (2023-11-01)
The Highest Anti-B Antibody Titer of 8192 in a Patient Undergoing ABO-incompatible Living-donor Liver Transplantation: How to Achieve Donor-specific B-cell Tolerance?
by: Tetsuya Tajima, MD, PhD, MPH, et al.
Published: (2025-09-01)
by: Tetsuya Tajima, MD, PhD, MPH, et al.
Published: (2025-09-01)
Aging is Associated With Constipation in Japanese Patients With Ulcerative Colitis: A Post Hoc Analysis
by: Sen Yagi MD, PhD, et al.
Published: (2023-11-01)
by: Sen Yagi MD, PhD, et al.
Published: (2023-11-01)
Characterization of Malnutrition in Atrial Functional Mitral Regurgitation
by: Tsukasa Murakami, MD, PhD, et al.
Published: (2025-08-01)
by: Tsukasa Murakami, MD, PhD, et al.
Published: (2025-08-01)
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study
by: Yasunori Murata, MD, PhD, et al.
Published: (2023-12-01)
by: Yasunori Murata, MD, PhD, et al.
Published: (2023-12-01)
Thoracoabdominal aorta replacement for a patient with Marfan syndrome with poor left ventricular functionCentral Message
by: Masahiko Ando, MD, PhD, MPH, et al.
Published: (2021-06-01)
by: Masahiko Ando, MD, PhD, MPH, et al.
Published: (2021-06-01)
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01)
by: Yusuke Inoue, MD, PhD, et al.
Published: (2025-08-01)
Efficacy and Safety of Allogeneic Islet Transplantation Demonstrated by a Multicenter Clinical Trial in Japan
by: Takayuki Anazawa, MD, PhD, et al.
Published: (2025-03-01)
by: Takayuki Anazawa, MD, PhD, et al.
Published: (2025-03-01)
Impact of pleural effusion at an early period after posterior spinal fusion for adolescent idiopathic scoliosis on future pulmonary function and lung volume
by: Masahiro Ozaki, MD, PhD, et al.
Published: (2023-12-01)
by: Masahiro Ozaki, MD, PhD, et al.
Published: (2023-12-01)
Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study
by: Hirotsugu Kenmotsu, MD, PhD, et al.
Published: (2024-11-01)
by: Hirotsugu Kenmotsu, MD, PhD, et al.
Published: (2024-11-01)
Modified Anterolateral Approach for Total Ankle Arthroplasty
by: Makoto Hirao MD, PhD, et al.
Published: (2021-06-01)
by: Makoto Hirao MD, PhD, et al.
Published: (2021-06-01)
A Multicenter Collaborative Survey of Peritoneal Lavage Cytology in Gastric Cancer Surgery: Interinstitutional Methodological Differences and Positive Rate
by: Keiichi Fujiya, MD, PhD, et al.
Published: (2025-09-01)
by: Keiichi Fujiya, MD, PhD, et al.
Published: (2025-09-01)
Successful endoscopic removal of a retained guidewire in the intrahepatic bile duct using a novel tapered sheath dilator
by: Rintaro Fukuda, MD, et al.
Published: (2024-08-01)
by: Rintaro Fukuda, MD, et al.
Published: (2024-08-01)
The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma
by: Hiroaki Kanemura, MD, MPH, PhD, et al.
Published: (2024-04-01)
by: Hiroaki Kanemura, MD, MPH, PhD, et al.
Published: (2024-04-01)
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L
by: Hideyuki Harada, MD, PhD, et al.
Published: (2025-06-01)
by: Hideyuki Harada, MD, PhD, et al.
Published: (2025-06-01)
Extensive brainstem lesions in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A case report
by: Yasuyuki Kojita, MD, PhD, et al.
Published: (2024-12-01)
by: Yasuyuki Kojita, MD, PhD, et al.
Published: (2024-12-01)
Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study
by: Takafumi Yuki, MD, PhD, et al.
Published: (2017-01-01)
by: Takafumi Yuki, MD, PhD, et al.
Published: (2017-01-01)
Comparing Three Different Anti–Programmed Death-Ligand 1 Antibodies in Immunohistochemical Evaluation of Combined Chemoimmunotherapy Response in Patients With NSCLC: A Prospective Study
by: Yuki Katayama, MD, PhD, et al.
Published: (2024-03-01)
by: Yuki Katayama, MD, PhD, et al.
Published: (2024-03-01)
Clinical Significance of Perioperative Minimal Residual Disease Detected by Circulating Tumor DNA in Patients With Lung Cancer With a Long Follow-up Data: An Exploratory Study
by: Shuta Ohara, MD, PhD, et al.
Published: (2025-03-01)
by: Shuta Ohara, MD, PhD, et al.
Published: (2025-03-01)
Lack of Association of Plasma Levels of Soluble Programmed Cell Death Protein 1, Programmed Death-Ligand 1, and CTLA-4 With Survival for Stage II to IIIA NSCLC After Complete Resection and Adjuvant Chemotherapy
by: Junko Tanizaki, MD, PhD, et al.
Published: (2023-12-01)
by: Junko Tanizaki, MD, PhD, et al.
Published: (2023-12-01)
Readmissions and costs in cadaveric and living-donor lobar lung transplantation: Analysis using a national database
by: Nobuyuki Yoshiyasu, MD, PhD, et al.
Published: (2023-12-01)
by: Nobuyuki Yoshiyasu, MD, PhD, et al.
Published: (2023-12-01)
Successful Laparoscopic Treatment of Pancreatic Metastasis From Sigmoid Colon Cancer: A Case Report
by: Masatsugu Ishii MD, PhD, et al.
Published: (2022-04-01)
by: Masatsugu Ishii MD, PhD, et al.
Published: (2022-04-01)
Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report
by: Masahiro Torasawa, MD, et al.
Published: (2024-04-01)
by: Masahiro Torasawa, MD, et al.
Published: (2024-04-01)
The ability of biomarkers to assess the severity of atopic dermatitis
by: Takeshi Nakahara, MD, PhD, et al.
Published: (2024-02-01)
by: Takeshi Nakahara, MD, PhD, et al.
Published: (2024-02-01)
Similar Items
-
Solid Predominant Histology and High Podoplanin Expression in Cancer-Associated Fibroblast Predict Primary Resistance to Osimertinib in EGFR-Mutated Lung Adenocarcinoma
by: Yuji Uehara, MD, et al.
Published: (2025-03-01) -
Nonneutralizing antibodies in Nordic persons with moderate hemophilia A and B (the MoHem study)
by: Ragnhild J. Måseide, MD, PhD, et al.
Published: (2024-11-01) -
CANOPY-N: A Phase 2 Study of Canakinumab or Pembrolizumab, Alone or in Combination, as Neoadjuvant Therapy in Patients With Resectable, Stage IB–IIIA NSCLC
by: Jay M. Lee, MD, et al.
Published: (2025-08-01) -
A comparison of treatment response to biologics in asthma-COPD overlap and pure asthma: Findings from the PRISM study
by: Ji-Su Shim, MD, PhD, et al.
Published: (2023-12-01) -
Systemic Oxidative Stress Level as a Pathological and Prognostic Factor in Myopic Choroidal Neovascularization
by: Jiying Wang, MD, PhD, et al.
Published: (2024-11-01)
